The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes

BACKGROUND: Psoriatic arthritis (PsA) is a chronic inflammatory arthritis which impacts significantly on the quality of life and work capacity of affected individuals. Recent evidence has shown that early control of inflammation in PsA leads to improved long-term outcomes. It is postulated that prom...

Descripción completa

Detalles Bibliográficos
Autores principales: De Marco, Gabriele, Helliwell, Philip, McGonagle, Dennis, Emery, Paul, Coates, Laura C., Hensor, Elizabeth M. A., Marzo-Ortega, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516354/
https://www.ncbi.nlm.nih.gov/pubmed/28720139
http://dx.doi.org/10.1186/s12891-017-1659-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516354/
https://www.ncbi.nlm.nih.gov/pubmed/28720139
http://dx.doi.org/10.1186/s12891-017-1659-1

Ejemplares similares